Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: J Trauma Acute Care Surg. 2017 Oct;83(4):635–642. doi: 10.1097/TA.0000000000001504

Hemorrhagic Shock and Tissue Injury Drive Distinct Plasma Metabolome Derangements in Swine

Nathan Clendenen 1,*, Geoffrey R Nunns 2,*, Ernest E Moore 3, Julie A Reisz 4, Eduardo Gonzalez 2, Erik Peltz 2, Christopher C Silliman 2,5,6, Miguel Fragoso 2, Travis Nemkov 4, Matthew J Wither 4, Kirk Hansen 5, Anirban Banerjee 2, Hunter B Moore 2, Angelo D’Alessandro 4
PMCID: PMC5608631  NIHMSID: NIHMS869172  PMID: 28463938

Abstract

Background

Tissue injury and hemorrhagic shock induce significant systemic metabolic reprogramming in animal models and critically injured patients. Recent expansions of the classic concepts of metabolomic aberrations in tissue injury and hemorrhage opened the way for novel resuscitative interventions based on the observed abnormal metabolic demands. We hypothesize that metabolic demands and resulting metabolic signatures in pig plasma will vary in response to isolated or combined tissue injury and hemorrhagic shock.

Methods

A total of 20 pigs underwent either isolated tissue injury, hemorrhagic shock, or combined tissue injury and hemorrhagic shock referenced to a sham protocol (n=5/group). Plasma samples were analyzed by UHPLC-MS.

Results

Hemorrhagic shock promoted a hypermetabolic state. Tissue injury alone dampened metabolic responses in comparison to sham and hemorrhagic shock, and attenuated the hypermetabolic state triggered by shock with respect to energy metabolism (glycolysis, glutaminolysis and Krebs cycle). Tissue injury and hemorrhagic shock had a more pronounced effect on nitrogen metabolism (arginine, polyamines and purine metabolism) than hemorrhagic shock alone.

Conclusion

Isolated or combined tissue injury and hemorrhagic shock result in distinct plasma metabolic signatures. These findings indicate that optimized resuscitative interventions in critically ill patients is possible based on identifying the severity of tissue injury and hemorrhage.

Keywords: Metabolism, Succinate, UHPLC-MS, Trauma, Hemorrhagic Shock

Background

Trauma is a major cause of disability and mortality in the United States and the leading cause of productive life years lost for individuals under 651, CDC data – June 2016. Uncontrolled hemorrhage and traumatic brain injury dominate early (<72 hrs from admission) death, while late deaths (>72 hours from admission) are primarily a result of coagulation defects and inflammatory states secondary to the initial injury. Inflammatory responses encompass a broad variety of disease including infectious complications, acute respiratory distress and multiple organ failure2 and have been recently related to mechanisms involving small molecule metabolites3. Early metabolic changes predispose the body for inflammatory4,5 and coagulopathic6 complications, but the mechanisms remain poorly understood. Despite advances in damage control surgery and resuscitation, patients continue to have substantial delayed morbidity7,8.

Metabolic changes generated during trauma were initially described by Cuthbertson as an early hypometabolic state followed by a hypermetabolic state, also known as the “ebb” and the “flow” phases9. With advances in technology subsequent investigators have approached this relevant question using mass spectrometry (MS) to provide a comprehensive description of metabolic pathways and their response to tissue injury. MS-based methods allow the simultaneous detection of hundreds of small molecules, which include metabolites from well described and crucial metabolic pathways. Using this approach, rodent models of hemorrhagic shock have been described to produce hyperglycemia, increased glycolysis, lipid mobilization, proteolysis, amino acid catabolism and impaired redox homeostasis5,1012. Similar observations were reported in critically ill patients4,13.

Prior experimental and retrospective clinical work has sought to define the plasma metabolome of trauma patients, but has not differentiated the key components of tissue injury (TI) and hemorrhagic shock (HS). These two entities have been shown to produce opposite effects on coagulation pathways in animal models, and it is reasonable to anticipate that they produce differential effects on the metabolome14. Additionally, while the HS model has been shown to mirror metabolic derangements observed in response to ischemia/hypoxia, the role of TI alone on the metabolic sequelae observed in trauma patients has not been hitherto elucidated.

Assessment of pathologic changes of the global metabolome in response to TI and shock can help identify translatable targeted therapies to reduce morbidity and mortality. For example early administration of plasma rather than normal saline improves survival and metabolic recovery in a rodent model of profound HS11. Recent investigations have highlighted the critical role of small molecule metabolites such as succinate (a citric acid cycle intermediate) as both a metabolic marker of tissue hypoxia and mitochondrial uncoupling, similar to lactate, as well as a driver of ischemia reperfusion injury through mitochondrial ROS15,16. Additionally, succinate has been linked to coagulopathy and ARDS through its role in IR injury3,17,18.

In this study we examined the dynamic changes in porcine plasma metabolome responses to HS or TI, either isolated or in combination (TI+HS), in comparison to sham controls (no TI or HS). The goal of this study was to determine the relative contribution of TI and HS to the overall plasma metabolome in a model relevant to critical care medicine. In previous studies utilizing rodent models, where minimum to no trauma was induced, neither laparotomy alone or anesthesia were sufficient to elicit the metabolic derangement that was instead observed upon mild and severe hemorrhage5,10,12,19. These models however did not include severe TI, and may have thus underestimated the relative contribution of traumatic injury to the etiology of metabolic alterations observed following hemorrhage in rodents and humans4,13. To test this hypothesis and expand on our previous observations in rodent models, we employed a porcine model of TI, in the presence or absence of HS. This represents a better translational model for higher mammals and thus for clinical translatability20. We hypothesized that the study of differential models of TI and HS would produce distinct metabolic signatures in plasma.

Materials and Methods

2.1 Animal model

The animal protocol was approved by the University of Colorado International Animal Care and Use Committee. A total of 20 male outbred immature swine (50–55 kg; n = 5 per group) underwent anesthesia with ketamine (20mg/kg) (VETone, Boise, ID, USA) and acepromazine (0.2mg/kg) (VETone, Boise, ID, USA) and xylazine (2mg/kg) (Akorn, Decatur, IL, USA), then were maintained on general anesthesia using isoflurane (0.5–2%) in room air, by mask. Animals underwent tracheostomy, femoral artery cannulation to measure blood pressure and induce hemorrhage. After tracheostomy, the animals were placed on mechanical ventilation to maintain O2 saturation > 90%. Upon completion of the experiment, the animal was euthanized by exsanguination followed by cardiectomy. An overview of the animal model is displayed in Figure 1. Each group (sham, TI, HS, and TI+HS) consisted of 5 animals. The plasma samples at each time point were pooled before analysis.

Figure 1.

Figure 1

A schematic representation of the swine model of poly-trauma and hemorrhage employed in this study. Model injury components are listed from 1 through 6 (top right corner).

2.2 Sham

Blood draws were performed at baseline, after 30, 60 and 90 min (consistent with the last time point of the TI group) to determine whether baseline values in the absence of HS or TI would result in plasma metabolic changes due to anesthesia and supine positioning.

2.3 Tissue Injury

Pigs underwent a severe TI model consisting of unilateral femur fracture with muscle crush, laparotomy with bowel crush, and clamshell thoracotomy with multiple surgeons operating simultaneously. Femur fracture was accomplished with a mid-thigh cut down to expose of the mid shaft periosteum of the femur. Direct blunt force of the bone was used to cause displacement and cortical disruption of the femur. A xiphoid to pubis laparotomy and clamshell thoracotomy were performed in a hemostatic manner. The bowel was crushed using 1 cm intervals over a 30 cm span of proximal jejunum. Blood draws were performed at baseline, and 30, 60 and 90 minutes after TI.

2.4 Hemorrhagic Shock

Pigs underwent hemorrhage to a mean arterial pressure of 25mm Hg for 30 minutes, followed by clamshell thoracotomy to access the descending aorta and 30 minutes of descending thoracic aortic cross clamping. No resuscitation fluids were given. Blood draws were performed at baseline, after 30 minutes of hemorrhage, after 30 minutes of descending thoracic aortic cross clamping and 30 minutes or at time of death after releasing aortic cross clamp.

2.5 Combined Tissue Injury and Hemorrhagic Shock

Pigs underwent simultaneous TI, followed by the HS protocol. Blood was drawn at time points as described in the hemorrhagic shock model.

2.6 Blood samples

Whole blood was collected through direct venous puncture of the femoral vein with a 21 gauge needle during each time point, and plasma was recovered through centrifugation (2500 g for 10 min at 4°C). Plasma samples from 5 individual animals were pooled at each time point prior to analysis.

2.7 Metabolomics analyses

Metabolomics analyses were performed as previously reported4,10. In brief, plasma samples were extracted in methanol, acetonitrile, and water at a ratio of 5:3:2 and agitated for 30 minutes at 4°C. Following centrifugation at 10,000g the supernatant was collected stored at -80°C until analysis with an UHPLC system. Metabolites were assigned using Maven software (Princeton, NJ, USA).

2.8 Statistical analysis

Relative quantitation was performed by exporting integrated peak area values into Excel (Microsoft, Redmond, CA, USA)). Hierarchical clustering analysis and partial least square-discriminant analysis (PLS-DA) for intra- and intergroup comparisons were performed through the software GENE-E (Broad Institute, Cambridge, MA, USA), as previously reported.21 Integrated peak area values in arbitrary units were graphed through GraphPad Prism 5.0 (GraphPad Software Inc., La Jolla, CA, USA) and figure panels were assembled through Photoshop CS5 (Adobe, Mountain View, CA, USA).

Results

A total of 168 metabolites were monitored in plasma from pigs (n = 5 per group) undergoing HS, TI, or a combination of TI+HS in comparison to sham animals (no trauma, no shock) (Supplementary Table 1). The model is summarized in Figure 1. Hierarchical clustering analysis and partial least square discriminant analysis (PC scores and loading values are provided in Supplementary Table 2) were performed to cluster metabolites following similar trends over the time course analyses in either group (a vectorial version of this figure is provided in Supplementary Figure 1). Three main clusters of metabolites were identified: i) metabolites increasing after HS and further increasing after TI+HS (Figure 2.left); ii) metabolites increasing only in the TI+HS group (Figure 2.top right); iii) metabolites increasing after HS and decreasing after TI+HS (Figure 2.bottom right).

Figure 2.

Figure 2

Heat maps of time course (0, 30, 60 and 90 min) metabolic changes in sham, shock, tissue injury (TI) and tissue injury combined with hemorrhage to MAP 25 mmHg (T+HS). Metabolite levels were Z-score normalized across all observations and median values were plotted following the color scheme in the bottom right corner (low: blue, high: red). Metabolites affected by shock alone (left), only by TI+HS (top right) or primed by shock but dampened by tissue injury (bottom right) are shown.

Metabolites in these three clusters are either part of glycolysis, the tricarboxylic acid cycle (TCA cycle), glutaminolysis (Figure 3), nitrogen metabolism (arginine catabolism, urea cycle, creatine metabolism and polyamines – Figure 4) and purine metabolism and oxidation (Figure 5).

Figure 3.

Figure 3

Time course analysis of glycolysis, TCA cycle and glutaminolysis markers in plasma of pigs undergoing shock (green), tissue injury (blue) or a combination of the two (red) in comparison to sham pigs (no tissue injury, no shock). Time points shown here are at 0, 15, 30, 45 and 60 min (0 min time point = after 30min from shock). Lines are representative of median values for each metabolite in each group.

Figure 4.

Figure 4

Time course analysis of nitrogen metabolism (arginine, urea cycle, creatine and polyamine metabolism) markers in plasma of pigs undergoing shock (green), tissue injury (blue) or a combination of the two (red) in comparison to sham pigs (no tissue injury, no shock). Time points shown here are at 0, 15, 30, 45 and 60 min (0 min time point = after 30min from shock). Lines are representative of median values for each metabolite in each group.

Figure 5.

Figure 5

Time course analysis of purine metabolism and oxidation markers in plasma of pigs undergoing shock (green), tissue injury (blue) or a combination of the two (red) in comparison to sham pigs (no tissue injury, no shock). Time points shown here are at 0, 15, 30, 45 and 60 min (0 min time point = after 30min from shock). Lines are representative of median values for each metabolite in each group.

Shock primed increases in plasma glycemia, while similar glycolytic rates were observed in shock and combined treatments in terms of lactatemia (Figure 3). Notably, TI alone resulted in the depression of plasma lactate levels compared to sham (Figure 3). Similarly, plasma accumulation of TCA cycle intermediates was the lowest in animals undergoing TI alone, while it was increased after HS and partially attenuated (at levels higher than in sham animals) in the combined TI and HS group (e.g. glutamine, alpha-ketoglutarate, malate, fumarate - Figure 3). On the other hand, combined TI and HS had the greatest effect on the time-course arginine consumption, creatine and polyamine (putrescine, spermidine, spermine) accumulation in plasma, followed by HS, while no significant effect was observed in response to TI alone or the sham procedure (Figure 4).

Similarly, increases in purine metabolism – involving the whole cascade from nicotinamide/adenosine/guanosine to inosine, hypoxanthine, urate and hydroxyisourate/allantoate - were primed by HS and further exacerbated by the combination of TI and HS (Figure 5). Conversely, TI alone resulted in lower levels of purine oxidation products hypoxanthine, urate and hydroxyisourate, compared to the sham protocol (Figure 5).

Discussion

Recent advancements in the field of metabolomics have opened the opportunity to revisit the classic concept of metabolic modulation in trauma and HS9. Understanding the metabolic sequelae to trauma and hemorrhage has relevant implications in defining the severity of injury in the intensive care setting (e.g. by measuring base deficit, strong anion gap and plasma lactate levels2224). At the same time, metabolic approaches are key in defining effective resuscitation strategies to meet the increased physiologic demands of critically injured patients by providing specific metabolic substrates such as glutamine12,2527 and arginine2832, either alone or in combination with omega-3 fatty acids and nucleotides33. Recently, we applied metabolomics technologies to delineate the metabolic derangements in hemorrhaged rodents and critically ill patients to identify shared perturbations of the post-shock metabolic pathways observed in the animal model and the clinical setting4,6,10,13. After confirming the potential clinical relevance of the rodent model, we moved to defining the time course development of metabolic derangements in plasma after early mild hemorrhage and late severe HS10. These observations from our and other groups suggest the potential significance of TCA cycle intermediates accumulating in post-shock plasma with respect to metabolic acidosis10,13,3436. Recent observations indicate a role for ischemic hypoxia-derived succinate in inflammation3,16, and for post-shock plasma succinate levels in fibrinolysis in rodents and humans6. Consequently, we performed stable isotope tracing experiments with heavy glucose and glutamine in vivo in rodents to determine the metabolic origin of these TCA cycle compounds5,12. Labeling propagation in metabolites downstream to glucose and glutamine oxidation revealed a role for a metabolic blockade at complex II of mitochondria in mediating the accumulation of TCA cycle intermediates, especially succinate, in post-shock animals5,12. Based on these data and from recent insights in the understanding of the mechanisms that underlie ischemia/reperfusion injury37,38, we postulated that plasma accumulation of carboxylic acids in vivo is at least in part explained by the uncoupling of normal electron flow in the respiratory complex chain of mitochondria under conditions of hemorrhagic hypoxia due to the lack of oxygen as the final acceptor of electrons in complex IV. However, it is unclear whether the metabolic derangements observed in these models and clinical patients are explained by HS alone or are a result of the combined effect of TI and HS. Therefore, we employed a porcine model of poly-trauma and HS, previously characterized through nuclear magnetic resonance (NMR)-based metabolomics technologies36, to disentangle the relative contribution of TI and HS.

We show here for the first time that HS primes metabolic derangements that are exacerbated by the addition of TI, especially with respect to nitrogen unbalance (arginine consumption and generation of polyamines) and purine catabolism. This is relevant in the light of the increasingly appreciated role of adenosine (and purines in general) in mediating early responses to shock10, provoking hypotension39, stimulating Na/K ATPase40, promoting a transient “hypometabolic” state (ebb phase) by attenuating sympathetic activation41, a phenomenon that confers a partial protection from HS-induced lung injury42. Similarly, polyamines accumulate in response to hemorrhage5,10 and traumatic brain injury43, markers of nitrogen metabolism unbalance that have been shown to correlate with increased fibrinolysis14. While the mechanisms remain unclear, it has been suggested that heparin anticoagulant reverses polyamine (e.g. spermine) induced coagulation defects in the presence of glycosaminoglycans44. Alternative mechanisms involve coagulation factor XIIIa, an enzyme with transglutaminase activity that bridges fibrin complexes to form an insoluble clot. The activity of this enzyme is partially inhibited by the higher than physiological concentrations of polyamines, which can be used as alternative substrates by factor XIIIa resulting in the formation of weaker clots45.

Notably, energy related metabolic pathways such as glycolysis and TCA cycle were dampened by TI in comparison to sham animals. Similarly, TI +HS attenuated the HS-dependent increase in the plasma level of metabolites such as glucose, glutamine, alpha-ketoglutarate, malate and fumarate. Though mechanistic studies are necessary, this observation is relevant in that it suggests that tissue injury promotes a “hypometabolic” state, likely triggered by the release of soluble metabolic mediators. While previous studies have described the alterations of the plasma and mesenteric lymph proteomes after severe trauma and hemorrhage4648, it will be interesting to determine whether TI alone is characterized by specific proteomics signatures (e.g. damage associated molecular patterns – DAMPS, histones, etcs) in comparison to shock alone or TI/HS. Additionally, metabolic enzymes released with TI in the bloodstream may play moonlighting functions49, such as the metabolic enzyme α-enolase participating in inflammatory cascades50.

In this study we employed a large animal model of TI and HS to disentangle the relative contribution of the systemic metabolic derangement observed in post-shock animal models and critically ill patients. While HS has a general effect on promoting a hypermetabolic state, TI promotes nitrogen imbalance (at the amino acid and purine catabolism level) while dampening energy metabolism (glycolysis and TCA cycle). This observation holds relevant clinical implications, as it suggests that metabolic resuscitation should be personalized on the basis of the severity of TI and HS. Follow up studies with non-human primate models of trauma and hemorrhage51 or clinical samples will further elucidate the impact of TI and HS on metabolism and will likely provide insights into the mechanism of metabolic derangements following TI and HS. Despite encouraging results, this study is preliminary in that a limited number of animals were investigated for a time-course analysis that stops at 90 min after TI and/or HS. Future studies will be necessary to investigate additional time points for prolonged analyses. Even though discovery-mode metabolomics based on relative quantitative approaches is an rapidly expanding area of investigation in the field of intensive care medicine, future targeted quantitative approaches and metabolic flux analyses in vivo will likely contribute additional complementary insights on the comparability of the swine model to what observed in civilian and military patients undergoing TI and HS, as well as to disentangle the relative contribution of specific metabolic substrates (e.g. glutamine, arginine, aspartate) in fueling the metabolic derangements observed here.

In summary, the current work identifies clear patterns of metabolic changes associated with TI, HS, and TI+HS. Notably, TI alone is characterized by a hypometabolic state which is in stark contrast to TI+HS which results in a hypermetabolic state. Thus if injured patients demonstrate similar patterns of altered metabolism they may benefit from targeting resuscitation to recovery of specific metabolic pathways based on the severity of TI and the presence or absence of HS.

Supplementary Material

Supplemental Data File _.doc_ .tif_ pdf_ etc.__1
Supplemental Data File _.doc_ .tif_ pdf_ etc.__2

Acknowledgments

AD received funds from the National Blood Foundation. This study is supported by the US Army Medical Research Acquisition Act of the Department of Defense under Contract Award Number W81XWH1220028 and the National Institutes of Health (P50 GM049222, T32 GM008315, and UMHL120877). The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Footnotes

The authors have declared no conflicts of interest.

Author Contribution

EM, AB, CS, HM designed the study.

GN, EG, EP, MF, HM performed surgeries on the animals, collected samples.

NC, JR TN, MW, KH and AD set up the metabolomics assays, performed metabolomics analyses.

AD prepared figures and tables, wrote the paper.

NC and AD revised the paper.

All the Authors critically contributed to the finalization of the manuscript and approved the final version that has been submitted for consideration of publication.

References

  • 1.Segui-Gomez M, MacKenzie EJ. Measuring the public health impact of injuries. Epidemiol Rev. 2003;25:3–19. doi: 10.1093/epirev/mxg007. [DOI] [PubMed] [Google Scholar]
  • 2.Acosta JA, Yang JC, Winchell RJ, Simons RK, Fortlage DA, Hollingsworth-Fridlund P, Hoyt DB. Lethal injuries and time to death in a level I trauma center. J Am Coll Surg. 1998;186(5):528–533. doi: 10.1016/s1072-7515(98)00082-9. [DOI] [PubMed] [Google Scholar]
  • 3.Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G, Frezza C, Bernard NJ, Kelly B, Foley NH, et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature. 2013;496(7444):238–242. doi: 10.1038/nature11986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.D’alessandro A, Nemkov T, Moore HB, Moore EE, Wither M, Nydam T, Slaughter A, Silliman CC, Banerjee A, Hansen KC. Metabolomics of trauma-associated death: shared and fluid-specific features of human plasma vs lymph. Blood Transfus Trasfus Sangue. 2016;14(2):185–194. doi: 10.2450/2016.0208-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.D’Alessandro A, Slaughter AL, Peltz ED, Moore EE, Silliman CC, Wither M, Nemkov T, Bacon AW, Fragoso M, Banerjee A, et al. Trauma/hemorrhagic shock instigates aberrant metabolic flux through glycolytic pathways, as revealed by preliminary (13)C-glucose labeling metabolomics. J Transl Med. 2015;13:253. doi: 10.1186/s12967-015-0612-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Wiener G, Moore HB, Moore EE, Gonzalez E, Diamond S, Zhu S, D’Alessandro A, Banerjee A. Shock releases bile acid inducing platelet inhibition and fibrinolysis. J Surg Res. 2015;195(2):390–395. doi: 10.1016/j.jss.2015.01.046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Masuno T, Moore EE, Cheng AM, Moore PK, Grant AR, Johnson JL. Prehospital hemoglobin-based oxygen carrier resuscitation attenuates postinjury acute lung injury. Surgery. 2005;138(2):335–341. doi: 10.1016/j.surg.2005.04.010. [DOI] [PubMed] [Google Scholar]
  • 8.Botha AJ, Moore FA, Moore EE, Kim FJ, Banerjee A, Peterson VM. Postinjury neutrophil priming and activation: an early vulnerable window. Surgery. 1995;118(2):358–364. doi: 10.1016/s0039-6060(05)80345-9. discussion 364–365. [DOI] [PubMed] [Google Scholar]
  • 9.Cuthbertson DP, Angeles Valero Zanuy MA, León Sanz ML. Post-shock metabolic response. 1942. Nutr Hosp. 2001;16(5):176–182. discussion 175–176. [PubMed] [Google Scholar]
  • 10.D’Alessandro A, Moore HB, Moore EE, Wither M, Nemkov T, Gonzalez E, Slaughter A, Fragoso M, Hansen KC, Silliman CC. Early hemorrhage triggers metabolic responses that build up during prolonged shock. Am J Physiol Regul Integr Comp Physiol. 2015;308(12):R1034–1044. doi: 10.1152/ajpregu.00030.2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.D’Alessandro A, Moore HB, Moore EE, Wither MJ, Nemkov T, Morton AP, Gonzalez E, Chapman MP, Fragoso M, Slaughter A, et al. Plasma First Resuscitation Reduces Lactate Acidosis, Enhances Redox Homeostasis, Amino Acid and Purine Catabolism in a Rat Model of Profound Hemorrhagic Shock. Shock Augusta Ga. 2016;46(2):173–182. doi: 10.1097/SHK.0000000000000588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Slaughter AL, D’Alessandro A, Moore EE, Banerjee A, Silliman CC, Hansen KC, Reisz JA, Fragoso M, Wither MJ, Bacon AW, et al. Glutamine metabolism drives succinate accumulation in plasma and the lung during hemorrhagic shock. J Trauma Acute Care Surg. 2016 doi: 10.1097/TA.0000000000001256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Peltz ED, D’Alessandro A, Moore EE, Chin T, Silliman CC, Sauaia A, Hansen KC, Banerjee A. Pathologic metabolism: an exploratory study of the plasma metabolome of critical injury. J Trauma Acute Care Surg. 2015;78(4):742–751. doi: 10.1097/TA.0000000000000589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Moore HB, Moore EE, Gonzalez E, Chapman MP, Chin TL, Silliman CC, Banerjee A, Sauaia A. Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy. J Trauma Acute Care Surg. 2014;77(6):811–817. doi: 10.1097/TA.0000000000000341. discussion 817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Niemann CU, Choi S, Behrends M, Hirose R, Noh J, Coatney JL, Roberts JP, Serkova NJ, Maher JJ. Mild hypothermia protects obese rats from fulminant hepatic necrosis induced by ischemia-reperfusion. Surgery. 2006;140(3):404–412. doi: 10.1016/j.surg.2006.01.021. [DOI] [PubMed] [Google Scholar]
  • 16.Chouchani ET, Pell VR, Gaude E, Aksentijević D, Sundier SY, Robb EL, Logan A, Nadtochiy SM, Ord EN, Smith AC, et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature. 2014;515(7527):431–435. doi: 10.1038/nature13909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Högberg C, Gidlöf O, Tan C, Svensson S, Nilsson-Öhman J, Erlinge D, Olde B. Succinate independently stimulates full platelet activation via cAMP and phosphoinositide 3-kinase-β signaling. J Thromb Haemost JTH. 2011;9(2):361–372. doi: 10.1111/j.1538-7836.2010.04158.x. [DOI] [PubMed] [Google Scholar]
  • 18.Spath B, Hansen A, Bokemeyer C, Langer F. Succinate reverses in-vitro platelet inhibition by acetylsalicylic acid and P2Y receptor antagonists. Platelets. 2012;23(1):60–68. doi: 10.3109/09537104.2011.590255. [DOI] [PubMed] [Google Scholar]
  • 19.Kinross JM, Alkhamesi N, Barton RH, Silk DB, Yap IK, Darzi AW, Holmes E, Nicholson JK. Global Metabolic Phenotyping in an Experimental Laparotomy Model of Surgical Trauma. J Proteome Res. 2011;10(1):277–287. doi: 10.1021/pr1003278. [DOI] [PubMed] [Google Scholar]
  • 20.Fülöp A, Turóczi Z, Garbaisz D, Harsányi L, Szijártó A. Experimental models of hemorrhagic shock: a review. Eur Surg Res Eur Chir Forsch Rech Chir Eur. 2013;50(2):57–70. doi: 10.1159/000348808. [DOI] [PubMed] [Google Scholar]
  • 21.Nemkov T, Hansen KC, D’Alessandro A. A Three-Minute Method for high-throughput quantitative metabolomics and quantitative tracing experiments of central carbon and nitrogen pathways. Rapid Commun Mass Spectrom RCM. 2017 doi: 10.1002/rcm.7834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Kaplan LJ, Kellum JA. Initial pH, base deficit, lactate, anion gap, strong ion difference, and strong ion gap predict outcome from major vascular injury. Crit Care Med. 2004;32(5):1120–1124. doi: 10.1097/01.ccm.0000125517.28517.74. [DOI] [PubMed] [Google Scholar]
  • 23.Husain FA, Martin MJ, Mullenix PS, Steele SR, Elliott DC. Serum lactate and base deficit as predictors of mortality and morbidity. Am J Surg. 2003;185(5):485–491. doi: 10.1016/s0002-9610(03)00044-8. [DOI] [PubMed] [Google Scholar]
  • 24.Rosenberg JC, Rush BF. Lethal endotoxin shock. Oxygen deficit, lactic acid levels, and other metabolic changes. JAMA. 1966;196(9):767–769. doi: 10.1001/jama.196.9.767. [DOI] [PubMed] [Google Scholar]
  • 25.Wernerman J. Glutamine supplementation. Ann Intensive Care. 2011;1:25. doi: 10.1186/2110-5820-1-25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.van Zanten ARH, Dhaliwal R, Garrel D, Heyland DK. Enteral glutamine supplementation in critically ill patients: a systematic review and meta-analysis. Crit Care Lond Engl. 2015;19:294. doi: 10.1186/s13054-015-1002-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Al Balushi RM, Cohen J, Banks M, Paratz JD. The clinical role of glutamine supplementation in patients with multiple trauma: a narrative review. Anaesth Intensive Care. 2013;41(1):24–34. doi: 10.1177/0310057X1304100106. [DOI] [PubMed] [Google Scholar]
  • 28.Bruins MJ, Soeters PB, Lamers WH, Deutz NE. l-Arginine supplementation in pigs decreases liver protein turnover and increases hindquarter protein turnover both during and after endotoxemia. Am J Clin Nutr. 2002;75(6):1031–1044. doi: 10.1093/ajcn/75.6.1031. [DOI] [PubMed] [Google Scholar]
  • 29.Kirk SJ, Barbul A. Role of Arginine in Trauma, Sepsis, and Immunity. J Parenter Enter Nutr. 1990;14(5 suppl):226S–229S. doi: 10.1177/014860719001400514. [DOI] [PubMed] [Google Scholar]
  • 30.Poeze M, Bruins MJ, Luiking YC, Deutz NE. Reduced caloric intake during endotoxemia reduces arginine availability and metabolism. Am J Clin Nutr. 2010;91(4):992–1001. doi: 10.3945/ajcn.2009.27812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Saito H, Trocki O, Wang SL, Gonce SJ, Joffe SN, Alexander JW. Metabolic and Immune Effects of Dietary Arginine Supplementation After Burn. Arch Surg. 1987;122(7):784–789. doi: 10.1001/archsurg.1987.01400190050010. [DOI] [PubMed] [Google Scholar]
  • 32.Zhou M, Martindale RG. Arginine in the Critical Care Setting. J Nutr. 2007;137(6):1687S–1692S. doi: 10.1093/jn/137.6.1687S. [DOI] [PubMed] [Google Scholar]
  • 33.Weimann A, Bastian L, Bischoff WE, Grotz M, Hansel M, Lotz J, Trautwein C, Tusch G, Schlitt HJ, Regel G. Influence of arginine, omega-3 fatty acids and nucleotide-supplemented enteral support on systemic inflammatory response syndrome and multiple organ failure in patients after severe trauma. Nutrition. 1998;14(2):165–172. doi: 10.1016/s0899-9007(97)00429-2. [DOI] [PubMed] [Google Scholar]
  • 34.Forni LG, McKinnon W, Lord GA, Treacher DF, Peron JM, Hilton PJ. Circulating anions usually associated with the Krebs cycle in patients with metabolic acidosis. Crit Care. 2005;9(5):R591–R595. doi: 10.1186/cc3806. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Cohen MJ, Serkova NJ, Wiener-Kronish J, Pittet J-F, Niemann CU. 1H-NMR-based metabolic signatures of clinical outcomes in trauma patients–beyond lactate and base deficit. J Trauma. 2010;69(1):31–40. doi: 10.1097/TA.0b013e3181e043fe. [DOI] [PubMed] [Google Scholar]
  • 36.Lexcen DR, Lusczek ER, Witowski NE, Mulier KE, Beilman GJ. Metabolomics classifies phase of care and identifies risk for mortality in a porcine model of multiple injuries and hemorrhagic shock. J Trauma Acute Care Surg. 2012;73:S147–S155. doi: 10.1097/TA.0b013e3182609821. [DOI] [PubMed] [Google Scholar]
  • 37.Pell VR, Chouchani ET, Frezza C, Murphy MP, Krieg T. Succinate metabolism: a new therapeutic target for myocardial reperfusion injury. Cardiovasc Res. 2016;111(2):134–141. doi: 10.1093/cvr/cvw100. [DOI] [PubMed] [Google Scholar]
  • 38.Tretter L, Patocs A, Chinopoulos C. Succinate, an intermediate in metabolism, signal transduction, ROS, hypoxia, and tumorigenesis. Biochim Biophys Acta. 2016;1857(8):1086–1101. doi: 10.1016/j.bbabio.2016.03.012. [DOI] [PubMed] [Google Scholar]
  • 39.Conlay LA, Evoniuk G, Wurtman RJ. Endogenous adenosine and hemorrhagic shock: effects of caffeine administration or caffeine withdrawal. Proc Natl Acad Sci USA. 1988;85(12):4483–4485. doi: 10.1073/pnas.85.12.4483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Darlington DN, Gann DS. Adenosine stimulates NA/K ATPase and prolongs survival in hemorrhagic shock. J Trauma. 2005;58(1):1–6. doi: 10.1097/01.ta.0000151185.63058.e3. [DOI] [PubMed] [Google Scholar]
  • 41.Tung C-S, Chu K-M, Tseng C-J, Yin T-H. Adenosine in hemorrhagic shock: Possible role in attenuating sympathetic activation. Life Sci. 1987;41(11):1375–1382. doi: 10.1016/0024-3205(87)90612-6. [DOI] [PubMed] [Google Scholar]
  • 42.Koscsó B, Trepakov A, Csóka B, Németh ZH, Pacher P, Eltzschig HK, Haskó G. Stimulation of A2B adenosine receptors protects against trauma-hemorrhagic shock-induced lung injury. Purinergic Signal. 2013;9(3):427–432. doi: 10.1007/s11302-013-9362-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Zahedi K, Huttinger F, Morrison R, Murray-Stewart T, Casero RA, Strauss KI. Polyamine Catabolism Is Enhanced after Traumatic Brain Injury. J Neurotrauma. 2009;27(3):515–525. doi: 10.1089/neu.2009.1097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Homma R, Mase A, Toida T, Kashiwagi K, Igarashi K. Modulation of blood coagulation and fibrinolysis by polyamines in the presence of glycosaminoglycans. Int J Biochem Cell Biol. 2005;37(9):1911–1920. doi: 10.1016/j.biocel.2005.04.014. [DOI] [PubMed] [Google Scholar]
  • 45.Mosher DF, Schad PE, Kleinman HK. Inhibition of blood coagulation factor XIIIa-mediated cross-linking between fibronectin and collagen by polyamines. J Supramol Struct. 1979;11(2):227–235. doi: 10.1002/jss.400110212. [DOI] [PubMed] [Google Scholar]
  • 46.D’Alessandro A, Dzieciatkowska M, Peltz ED, Moore EE, Jordan JR, Silliman CC, Banerjee A, Hansen KC. Dynamic changes in rat mesenteric lymph proteins following trauma using label-free mass spectrometry. Shock Augusta Ga. 2014;42(6):509–517. doi: 10.1097/SHK.0000000000000259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Dzieciatkowska M, D’Alessandro A, Moore EE, Wohlauer M, Banerjee A, Silliman CC, Hansen KC. Lymph is not a plasma ultrafiltrate: a proteomic analysis of injured patients. Shock Augusta Ga. 2014;42(6):485–498. doi: 10.1097/SHK.0000000000000249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Dzieciatkowska M, Wohlauer MV, Moore EE, Damle S, Peltz E, Campsen J, Kelher M, Silliman C, Banerjee A, Hansen KC. Proteomic analysis of human mesenteric lymph. Shock Augusta Ga. 2011;35(4):331–338. doi: 10.1097/SHK.0b013e318206f654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Huberts DHEW, van der Klei IJ. Moonlighting proteins: An intriguing mode of multitasking. Biochim Biophys Acta BBA - Mol Cell Res. 2010;1803(4):520–525. doi: 10.1016/j.bbamcr.2010.01.022. [DOI] [PubMed] [Google Scholar]
  • 50.Bock A, Tucker N, Kelher MR, Khan SY, Gonzalez E, Wohlauer M, Hansen K, Dzieciatkowska M, Sauaia A, Banerjee A. α-Enolase Causes Proinflammatory Activation of Pulmonary Microvascular Endothelial Cells and Primes Neutrophils Through Plasmin Activation of Protease-Activated Receptor 2. Shock Augusta Ga. 2015;44(2):137–142. doi: 10.1097/SHK.0000000000000394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Bock A, Tucker N, Kelher MR, Khan SY, Gonzalez E, Wohlauer M, Hansen K, Dzieciatkowska M, Sauaia A, Banerjee A. Development of a Nonhuman Primate (Rhesus Macaque) Model of Uncontrolled Traumatic Liver Hemorrhage. Shock Augusta Ga. 2015;44(Suppl 1):114–122. doi: 10.1097/SHK.0000000000000335. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Data File _.doc_ .tif_ pdf_ etc.__1
Supplemental Data File _.doc_ .tif_ pdf_ etc.__2

RESOURCES